Cargando…
REPLY: Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy
Autores principales: | Aziz-Bose, Rahela, Armenian, Saro H., Nohria, Anju, Kenney, Lisa B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982201/ https://www.ncbi.nlm.nih.gov/pubmed/36875896 http://dx.doi.org/10.1016/j.jaccao.2022.12.004 |
Ejemplares similares
-
Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy
por: Mohan Singh Sindhi, Rithik, et al.
Publicado: (2023) -
Delphi Panel Consensus Recommendations for Screening and Managing Childhood Cancer Survivors at Risk for Cardiomyopathy
por: Aziz-Bose, Rahela, et al.
Publicado: (2022) -
We Must Consider a Growing Opioid Epidemic in Older People
por: Hudson, Murray A J, et al.
Publicado: (2022) -
Strategies to Prevent Anthracycline-Related Congestive Heart Failure in Survivors of Childhood Cancer
por: Armenian, Saro H., et al.
Publicado: (2012) -
Diabetes in childhood cancer survivors: emerging concepts in pathophysiology and future directions
por: Bhandari, Rusha, et al.
Publicado: (2023)